Karen M Kuntz

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi request reprint Cost-effectiveness of diagnostic strategies for patients with chest pain
    K M Kuntz
    Brigham and Women s Hospital, and Harvard Medical School, Boston, Massachusetts, USA
    Ann Intern Med 130:709-18. 1999
  2. ncbi request reprint Expert panel vs decision-analysis recommendations for postdischarge coronary angiography after myocardial infarction
    K M Kuntz
    Program on the Economic Evaluation of Medical Technology, Department of Health Policy and Management, Harvard School of Public Health, Boston, Mass 02115 5924, USA
    JAMA 282:2246-51. 1999
  3. ncbi request reprint Cost-effectiveness of fusion with and without instrumentation for patients with degenerative spondylolisthesis and spinal stenosis
    K M Kuntz
    Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115 5924, USA
    Spine (Phila Pa 1976) 25:1132-9. 2000
  4. ncbi request reprint A novel approach to defining the relationship between lung function and symptom status in asthma
    Karen M Kuntz
    Department of Health Policy and Management, Harvard School of Public Health, 718 Huntington Ave, Boston, MA, USA
    J Clin Epidemiol 55:11-8. 2002
  5. ncbi request reprint Assessing the sensitivity of decision-analytic results to unobserved markers of risk: defining the effects of heterogeneity bias
    Karen M Kuntz
    Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115, USA
    Med Decis Making 22:218-27. 2002
  6. ncbi request reprint The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis
    Rinaa S Punglia
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Cancer 106:2576-82. 2006
  7. pmc Effects of Helicobacter pylori infection and smoking on gastric cancer incidence in China: a population-level analysis of trends and projections
    Jennifer M Yeh
    Center for Health Decision Science, Harvard School of Public Health, 718 Huntington Avenue, 2nd Floor, Boston, MA 02115, USA
    Cancer Causes Control 20:2021-9. 2009
  8. pmc Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results
    Jennifer M Yeh
    Department of Health Policy and Management, Program in Health Decision Science, Harvard School of Public Health, Boston, MA 02115, USA
    Int J Cancer 124:157-66. 2009
  9. pmc Modeling the potential impact of a prescription drug copayment increase on the adult asthmatic medicaid population
    Seung Jin Bae
    Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
    Value Health 11:110-8. 2008
  10. ncbi request reprint Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma
    Anne L Fuhlbrigge
    Channing Laboratory, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    Pediatrics 118:e347-55. 2006

Detail Information

Publications59

  1. ncbi request reprint Cost-effectiveness of diagnostic strategies for patients with chest pain
    K M Kuntz
    Brigham and Women s Hospital, and Harvard Medical School, Boston, Massachusetts, USA
    Ann Intern Med 130:709-18. 1999
    ..Many noninvasive tests exist to determine whether patients should undergo coronary angiography. The routine use of coronary angiography without previous noninvasive testing is typically not advocated...
  2. ncbi request reprint Expert panel vs decision-analysis recommendations for postdischarge coronary angiography after myocardial infarction
    K M Kuntz
    Program on the Economic Evaluation of Medical Technology, Department of Health Policy and Management, Harvard School of Public Health, Boston, Mass 02115 5924, USA
    JAMA 282:2246-51. 1999
    ..Expert panels and decision-analytic techniques are increasingly used to determine the appropriateness of medical interventions, but these 2 approaches use different methods to process evidence...
  3. ncbi request reprint Cost-effectiveness of fusion with and without instrumentation for patients with degenerative spondylolisthesis and spinal stenosis
    K M Kuntz
    Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115 5924, USA
    Spine (Phila Pa 1976) 25:1132-9. 2000
    ..A cost-effectiveness study was performed from the societal perspective...
  4. ncbi request reprint A novel approach to defining the relationship between lung function and symptom status in asthma
    Karen M Kuntz
    Department of Health Policy and Management, Harvard School of Public Health, 718 Huntington Ave, Boston, MA, USA
    J Clin Epidemiol 55:11-8. 2002
    ..Functional relationships between FEV(1) percent predicted and asthma-related symptoms can be useful for inferring the effect on the symptoms of a population associated with overall improvements in lung function...
  5. ncbi request reprint Assessing the sensitivity of decision-analytic results to unobserved markers of risk: defining the effects of heterogeneity bias
    Karen M Kuntz
    Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115, USA
    Med Decis Making 22:218-27. 2002
    ..This analysis provides a general framework to determine when issues of heterogeneity may be important...
  6. ncbi request reprint The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis
    Rinaa S Punglia
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Cancer 106:2576-82. 2006
    ..However, the optimal sequencing of AIs and tamoxifen as adjuvant therapy is not known and may differ for biologic subsets of cancers...
  7. pmc Effects of Helicobacter pylori infection and smoking on gastric cancer incidence in China: a population-level analysis of trends and projections
    Jennifer M Yeh
    Center for Health Decision Science, Harvard School of Public Health, 718 Huntington Avenue, 2nd Floor, Boston, MA 02115, USA
    Cancer Causes Control 20:2021-9. 2009
    ..Our aim was to (1) retrospectively estimate the effects of Helicobacter pylori (H. pylori) and smoking on past gastric cancer incidence and (2) project how interventions on these two risk factors can reduce future incidence...
  8. pmc Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results
    Jennifer M Yeh
    Department of Health Policy and Management, Program in Health Decision Science, Harvard School of Public Health, Boston, MA 02115, USA
    Int J Cancer 124:157-66. 2009
    ..These results illustrate the potential promise of a gastric cancer screening program and provide rationale for urgent clinical studies to move the prevention agenda forward...
  9. pmc Modeling the potential impact of a prescription drug copayment increase on the adult asthmatic medicaid population
    Seung Jin Bae
    Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
    Value Health 11:110-8. 2008
    ..We sought to determine the likely health outcomes and cost shifts attributable to this copayment increase using the example of inhaled corticosteroids (ICS) use among adult asthmatic Medicaid beneficiaries...
  10. ncbi request reprint Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma
    Anne L Fuhlbrigge
    Channing Laboratory, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    Pediatrics 118:e347-55. 2006
    ..The objective of this analysis was to examine the association between FEV1% and future risk of exacerbations among a well-characterized population of children with asthma...
  11. ncbi request reprint Cost-effectiveness analysis of computerized tomography in the routine follow-up of patients after primary treatment for Hodgkin's disease
    Beverly A Guadagnolo
    Joint Center for Radiation Therapy Harvard Radiation Oncology Program, Harvard School of Public Health, Harvard University, Boston, MA 02215, USA
    J Clin Oncol 24:4116-22. 2006
    ..To estimate the clinical benefits and cost effectiveness of computed tomography (CT) in the follow-up of patients with complete response (CR) after treatment for Hodgkin's disease (HD)...
  12. ncbi request reprint Cost-effectiveness of interferon beta-1a, interferon beta-1b, and glatiramer acetate in newly diagnosed non-primary progressive multiple sclerosis
    Lisa A Prosser
    Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA 02215, USA
    Value Health 7:554-68. 2004
    ..To perform a cost-effectiveness analysis of three immunomodulatory treatments for newly diagnosed nonprimary progressive MS: interferon beta-1a, interferon beta-1b, and glatiramer acetate...
  13. pmc Cost effectiveness and screening interval of lipid screening in Hodgkin's lymphoma survivors
    Aileen B Chen
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, MA 02115, USA
    J Clin Oncol 27:5383-9. 2009
    ..We evaluated the cost effectiveness of lipid screening in survivors of HL and compared different screening intervals...
  14. pmc Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination
    Jeremy D Goldhaber-Fiebert
    Doctoral Program in Health Policy, Decision Science Concentration, Harvard University, Cambridge, MA, USA
    J Natl Cancer Inst 100:308-20. 2008
    ....
  15. ncbi request reprint Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis
    Rinaa S Punglia
    Division of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Clin Oncol 23:5178-87. 2005
    ..Options include the antiestrogen tamoxifen, estrogen deprivation with aromatase inhibitors, and sequential therapy with tamoxifen and then an aromatase inhibitor...
  16. doi request reprint Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study
    Pamela M McMahon
    Institute for Technology Assessment, Massachusetts General Hospital, 101 Merrimac St, 10th Floor, Boston, MA 02114, USA
    Radiology 248:278-87. 2008
    ....
  17. ncbi request reprint Cost-effectiveness of inhaled steroids in asthma: impact of effect on bone mineral density
    Anne L Fuhlbrigge
    Channing Laboratory, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    J Allergy Clin Immunol 117:359-66. 2006
    ..The effects of inhaled corticosteroid (ICS) preparations on bone health have been debated. Multiple analyses have been published examining the question, with mixed results...
  18. ncbi request reprint Association between preference-based health-related quality of life and asthma severity
    Marilyn L Moy
    Division of Pulmonary and Critical Care Medicine and Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    Ann Allergy Asthma Immunol 92:329-34. 2004
    ..International guidelines have been developed to guide medical management according to asthma severity defined by lung function and symptom frequency...
  19. ncbi request reprint Impact of preoperative staging and chemoradiation versus postoperative chemoradiation on outcome in patients with rectal cancer: a decision analysis
    Jennifer J Telford
    Division of Gastroenterology, Brigham and Women s Hospital, Boston, MA, USA
    J Natl Cancer Inst 96:191-201. 2004
    ..We used a decision analysis to compare the two strategies for rectal cancer management...
  20. pmc Derivation of background mortality by smoking and obesity in cancer simulation models
    Y Claire Wang
    Department of Health Policy and Management, Columbia Mailman School of Public Health, New York, NY 10032, USA
    Med Decis Making 33:176-97. 2013
    ..However, this can lead to bias because common risk factors such as smoking and obesity also predispose individuals for deaths from other causes such as cardiovascular disease...
  21. pmc Cost-effectiveness of omalizumab in adults with severe asthma: results from the Asthma Policy Model
    Ann C Wu
    Department of Ambulatory Care and Prevention, Harvard Medical School and Children s Hospital, Boston, MA 02215 5301, USA
    J Allergy Clin Immunol 120:1146-52. 2007
    ..Given the high acquisition cost of omalizumab, its role and cost-effectiveness in disease management require definition...
  22. ncbi request reprint Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia
    Gavin J Blake
    Center for Cardiovascular Disease Prevention, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    Am J Med 114:485-94. 2003
    ..However, no cost-effectiveness analyses have been performed to assist in determining whether large-scale randomized trials are merited to test this hypothesis...
  23. ncbi request reprint A single measure of FEV1 is associated with risk of asthma attacks in long-term follow-up
    Barrett T Kitch
    Division of Pulmonary and Critical Care Medicine, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    Chest 126:1875-82. 2004
    ..Clinical practice guidelines for asthma care emphasize the use of objective measures of asthma severity, and yet little data exist on the relationship between FEV(1) and asthma outcomes over long-term follow-up...
  24. ncbi request reprint Using economic analysis to evaluate the potential of multimodality therapy for elderly patients with locally advanced pancreatic cancer
    Monika K Krzyzanowska
    Department of Adult Oncology, Dana Farber Cancer Institute, Boston, MA, USA
    Int J Radiat Oncol Biol Phys 67:211-8. 2007
    ..Economic modeling can be used to explore the potential of such novel therapies and to inform clinical trial design...
  25. pmc Rescreening of persons with a negative colonoscopy result: results from a microsimulation model
    Amy B Knudsen
    Institute for Technology Assessment, Massachusetts General Hospital, 101 Merrimac Street, 10th Floor, Boston, MA 02114, USA
    Ann Intern Med 157:611-20. 2012
    ..Persons with a negative result on screening colonoscopy are recommended to repeat the procedure in 10 years...
  26. ncbi request reprint A potential error in evaluating cancer screening: a comparison of 2 approaches for modeling underlying disease progression
    Sue J Goldie
    Harvard Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115 5924, USA
    Med Decis Making 23:232-41. 2003
    ..Evaluating cancer screening often requires modeling the underlying disease process and not observed disease, particularly in the absence of direct evidence linking screening to a survival benefit...
  27. pmc Cost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer
    Jennifer M Yeh
    Center for Health Decision Science, Harvard School of Public Health, Boston, MA 02115, USA
    Cancer 116:2941-53. 2010
    ..The objective of this study was to estimate the clinical benefits and cost-effectiveness of treatment and endoscopic surveillance to prevent gastric cancer...
  28. ncbi request reprint Estimation of mortality rates for disease simulation models using Bayesian evidence synthesis
    Pamela M McMahon
    Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA 02114, USA
    Med Decis Making 26:497-511. 2006
    ..This approach is suggested when modeling a disease that causes a large proportion of all-cause mortality, particularly when mortality from the disease of interest and other-cause mortality are both affected by the same risk factor...
  29. doi request reprint A cost-effectiveness analysis of folic acid fortification policy in the United States
    Tanya Gk Bentley
    The Faculty of Arts and Sciences, Harvard University PhD Program in Health Policy, Cambridge, MA, USA
    Public Health Nutr 12:455-67. 2009
    ..To quantify the health and economic outcomes associated with changes in folic acid consumption following the fortification of enriched grain products in the USA...
  30. doi request reprint Development of an empirically calibrated model of gastric cancer in two high-risk countries
    Jennifer M Yeh
    Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, 718 Huntington Avenue, 2nd Floor, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 17:1179-87. 2008
    ..As better data become available, the model can be refined and recalibrated, and, as such, be used as an iterative tool to assess the likely health and economic outcomes associated with gastric cancer prevention strategies...
  31. ncbi request reprint Limitations of acceptability curves for presenting uncertainty in cost-effectiveness analysis
    Bas Groot Koerkamp
    Harvard Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, USA
    Med Decis Making 27:101-11. 2007
    ..Presenting the value of information in addition to these intervals allows policy makers to evaluate the need for more empirical research...
  32. ncbi request reprint Multiparameter calibration of a natural history model of cervical cancer
    Jane J Kim
    Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115, USA
    Am J Epidemiol 166:137-50. 2007
    ..The authors found that leveraging primary data from longitudinal studies provides unique opportunities for model parameterization of the unobservable nature of HPV infection and its role in the development of cervical cancer...
  33. doi request reprint Effects of categorizing continuous variables in decision-analytic models
    Tanya G K Bentley
    Faculty of Arts and Sciences, Harvard University, Cambridge, Massachusetts, USA
    Med Decis Making 29:549-56. 2009
    ..This analysis assessed the tradeoffs between model bias and complexity and/or data limitations when categorizing continuous risk factors in Markov models...
  34. ncbi request reprint Impact of age, benign prostatic hyperplasia, and cancer on prostate-specific antigen level
    Rinaa S Punglia
    Department of Radiation Oncology, Brigham and Women s Hospital, Boston, MA 02115, USA
    Cancer 106:1507-13. 2006
    ..Correcting for verification bias, the means and variances of PSA values were estimated in specific clinical scenarios...
  35. pmc Contribution of H. pylori and smoking trends to US incidence of intestinal-type noncardia gastric adenocarcinoma: a microsimulation model
    Jennifer M Yeh
    Center for Health Decision Science, Harvard School of Public Health, Boston, Massachusetts, United States of America
    PLoS Med 10:e1001451. 2013
    ..We sought to estimate the contribution of risk factor trends on past and future intestinal-type noncardia gastric adenocarcinoma (NCGA) incidence...
  36. ncbi request reprint Effects of rofecoxib and naproxen on life expectancy among patients with rheumatoid arthritis: a decision analysis
    Hyon K Choi
    Department of Health Policy and Management, Boston, Massachusetts, USA
    Am J Med 116:621-9. 2004
    ..We examined the effects of these competing adverse events on life expectancy in patients with rheumatoid arthritis...
  37. pmc Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination
    Jeremy D Goldhaber-Fiebert
    Department of Health Policy and Management, Harvard School of Public Health, Boston, USA
    Popul Health Metr 5:11. 2007
    ..S. policy choices for cervical cancer prevention, we developed a model of human papillomavirus (HPV) and cervical cancer, explicitly incorporating uncertainty about the natural history of disease...
  38. ncbi request reprint Estimating the energy gap among US children: a counterfactual approach
    Y Claire Wang
    Department of Health Policy and Management, Harvard School of Public Health, 718 Huntington Ave, 2nd Floor, Boston, MA 02115, USA
    Pediatrics 118:e1721-33. 2006
    ..Our goal was to quantify the magnitude of energy imbalance responsible for the increase in body weight among US children during the periods 1988-1994 and 1999-2002...
  39. pmc Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis
    G Scott Gazelle
    Institute for Technology Assessment, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Zero Emerson Place, Suite 2H, Boston, MA 02114, USA
    Ann Surg 237:544-55. 2003
    ....
  40. ncbi request reprint Patient and community preferences for treatments and health states in multiple sclerosis
    Lisa A Prosser
    Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA 02215, USA
    Mult Scler 9:311-9. 2003
    ..To examine preferences for treatments and health states for patients with relapsing-remitting MS and members of the community...
  41. ncbi request reprint Radiation therapy plus tamoxifen versus tamoxifen alone after breast-conserving surgery in postmenopausal women with stage I breast cancer: a decision analysis
    Rinaa S Punglia
    Joint Center for Radiation Therapy, Harvard Medical School, Boston, MA, USA
    J Clin Oncol 21:2260-7. 2003
    ....
  42. ncbi request reprint Outcomes and cost-effectiveness of alternative staging strategies for non-small-cell lung cancer
    Nestor F Esnaola
    Department of Surgery, Brigham and Women s Hospital, Harvard School of Public Health, Boston, MA, USA
    J Clin Oncol 20:263-73. 2002
    ..To identify the optimal strategy for staging the mediastinum of patients with known non-small-cell lung cancer (NSCLC), stratified by tumor (T) classification...
  43. ncbi request reprint Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen
    Rinaa S Punglia
    Joint Center for Radiation Therapy, Harvard Medical School, Boston, USA
    N Engl J Med 349:335-42. 2003
    ..We assessed the screening characteristics of the prostate-specific antigen (PSA) measurement after correction for verification bias...
  44. ncbi request reprint Projected life-expectancy gains with statin therapy for individuals with elevated C-reactive protein levels
    Gavin J Blake
    Center for Cardiovascular Disease Prevention, Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    J Am Coll Cardiol 40:49-55. 2002
    ..We sought to estimate the potential gains in life expectancy achieved with statin therapy for individuals without overt hyperlipidemia but with elevated C-reactive protein (CRP) levels...
  45. ncbi request reprint Forecasting the obesity epidemic in the aging U.S. population
    Y Claire Wang
    Department of Health Policy and Management, Columbia Mailman School of Public Health, 600 W 168th Street, 6th Floor, New York, NY 10032, USA
    Obesity (Silver Spring) 15:2855-65. 2007
    ..The objective was to forecast BMI distribution in the U.S. population along with demographic changes based on past race-, sex-, and birth cohort-specific secular trends...
  46. ncbi request reprint Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis
    Kunihiro Nishimura
    Department of Health Policy Management, Harvard School of Public Health, Boston, Massachusetts 02215, USA
    Ann Intern Med 146:797-808. 2007
    ..Rheumatoid factor (RF) and autoantibodies against cyclic citrullinated peptide (CCP) are markers that might help physicians diagnose rheumatoid arthritis...
  47. ncbi request reprint The relationship between risk attitude and treatment choice in patients with relapsing-remitting multiple sclerosis
    Lisa A Prosser
    Department of Ambulatory Care and Prevention, Harvard Medical School, 133 Brookline Ave, 6th Floor, Boston, MA 02215, USA
    Med Decis Making 22:506-13. 2002
    ....
  48. ncbi request reprint The impact of a partially effective HIV vaccine on a population of intravenous drug users in Bangkok, Thailand: a dynamic model
    Elizabeth Bogard
    Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    J Acquir Immune Defic Syndr 29:132-41. 2002
    ..These results agree with analyses of the epidemic among gay men. If injection drug behavior is indeed modifiable, our findings have significant policy and planning implications...
  49. ncbi request reprint Cost effectiveness of mammography screening for Chinese women
    Irene O L Wong
    Department of Community Medicine and School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
    Cancer 110:885-95. 2007
    ..The authors estimated the cost effectiveness of biennial mammography in Hong Kong Chinese women to inform evidence-based screening policies...
  50. ncbi request reprint Pretreatment imaging workup for patients with intermittent claudication: a cost-effectiveness analysis
    Karen Visser
    Program for the Assessment of Radiological Technology Program, Department of Epidemiology and Biostatistics, Erasmus MC University Medical Center Rotterdam, The Netherlands
    J Vasc Interv Radiol 14:53-62. 2003
    ..To determine the optimal imaging strategy in pretreatment workup of patients with intermittent claudication with use of noninvasive imaging modalities and intraarterial digital subtraction angiography (DSA)...
  51. ncbi request reprint A cost effectiveness analysis of treatment options for methotrexate-naive rheumatoid arthritis
    Hyon K Choi
    Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA
    J Rheumatol 29:1156-65. 2002
    ..Given wide variability in efficacy and cost among different treatment options, we sought to determine their relative cost effectiveness to help guide policy in different cost constrained settings...
  52. ncbi request reprint Cost-effectiveness targets for multi-detector row CT angiography in the work-up of patients with intermittent claudication
    Karen Visser
    Program for the Assessment of Radiological Technology, Department of Epidemiology and Biostatistics, Erasmus MC, University Medical Center Rotterdam, Dr Molewaterplein 50, Rm Ee21 40B, 3015GE Rotterdam, The Netherlands
    Radiology 227:647-56. 2003
    ....
  53. ncbi request reprint Adjuvant ovarian suppression versus chemotherapy for premenopausal, hormone-responsive breast cancer: quality of life and efficacy tradeoffs
    Elena B Elkin
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 44, New York, NY 10021, USA
    Breast Cancer Res Treat 93:25-34. 2005
    ..We used a decision-analytic framework to evaluate tradeoffs between efficacy and quality of life in the choice between these treatments...
  54. ncbi request reprint HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis
    Elena B Elkin
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 44, New York, NY 10021, USA
    J Clin Oncol 22:854-63. 2004
    ..Several tests of varying accuracy and cost are available to identify candidates for trastuzumab. We estimated the cost-effectiveness of alternative HER-2 testing and trastuzumab treatment strategies...
  55. ncbi request reprint Correction: cost-effectiveness of statins in older patients with myocardial infarction
    David A Ganz
    Ann Intern Med 136:635. 2002
  56. ncbi request reprint Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease
    Jean Michel Gaspoz
    Clinique de M├ędecine II and the Division of Cardiology, Hopitaux Universitaires, Geneva, Switzerland
    N Engl J Med 346:1800-6. 2002
    ..We estimated the cost effectiveness of the increased use of aspirin, clopidogrel, or both for secondary prevention in patients with coronary heart disease...
  57. ncbi request reprint Economic evaluation of weight loss interventions in overweight and obese women
    Larissa Roux
    Department of Community Health Sciences, University of Calgary, Canada
    Obesity (Silver Spring) 14:1093-106. 2006
    ..To conduct a clinical and economic evaluation of outpatient weight loss strategies in overweight and obese adult U.S. women...
  58. pmc Population-level changes in folate intake by age, gender, and race/ethnicity after folic acid fortification
    Tanya G K Bentley
    Faculty of Arts and Sciences, Harvard University, Cambridge, Mass, USA
    Am J Public Health 96:2040-7. 2006
    ..We sought to quantify the impact of the 1998 US Food and Drug Administration (FDA) folic acid fortification policy by estimating folate intake at the population level...
  59. pmc Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force
    Ann G Zauber
    Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Ann Intern Med 149:659-69. 2008
    ..The U.S. Preventive Services Task Force requested a decision analysis to inform their update of recommendations for colorectal cancer screening...